Anastrozole and everolimus in advanced gynecologic and breast malignancies: activity and molecular alterations in the PI3K/AKT/mTOR pathway.
Wheler JJ, Moulder SL, Naing A, Janku F, Piha-Paul SA, Falchook GS, Zinner R, Tsimberidou AM, Fu S, Hong DS, Atkins JT, Yelensky R, Stephens PJ, Kurzrock R.
Wheler JJ, et al. Among authors: kurzrock r.
Oncotarget. 2014 May 30;5(10):3029-38. doi: 10.18632/oncotarget.1799.
Oncotarget. 2014.
PMID: 24912489
Free PMC article.
Clinical Trial.